Jim Gallarda's Biography

Jim Gallarda, Senior Program Officer, Bill & Melinda Gates Foundation

Jim Gallarda, Senior Program Officer, ITS, oversees the diagnostic portfolio for the TB PST, and serves as a resource for all foundation diagnostic needs related to molecular technologies. Jim brings systems-level end-to-end thinking in diagnostic-related R&D, clinical, regulatory, and commercialization, both in the developed & developing world.

Jim has a 20-year background in industry developing in vitro diagnostics at Abbott & Roche. He is experienced in blood screening infectious disease assay development, overseeing multiple teams developing immunodiagnostic & PCR systems for HIV-1, HIV-2, HCV, HBV and WNV. Prior to joining the Bill & Melinda Gates Foundation he was with Novartis Pharmaceuticals (in Cambridge MA) leading companion diagnostics program for assays used to assess the effectiveness of tyrosine kinase inhibitors for patients with CML.

Do We Need a GAVI For Diagnostics in the Developing World?

Tuesday, 2 October 2018 at 17:15

Add to Calendar ▼2018-10-02 17:15:002018-10-02 18:15:00Europe/LondonDo We Need a GAVI For Diagnostics in the Developing World?SELECTBIOenquiries@selectbiosciences.com

Silos are the chief impediment to progress in global health. Technology innovation is needed, but not sufficient to achieve impact. Adopting an “end-to-end” strategy requires deep knowledge and connectiveness among supply, demand, and facilitating stakeholders. GAVI, The Vaccine Alliance, provides a model that might work for diagnostics.

Add to Calendar ▼2018-10-01 00:00:002018-10-03 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization "Track B"SELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors